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immunization coverage and timeliness among the 2169 enrolled children (median age: 12.5 months).
86% had vaccine cards available, >95% had received three doses of DTP-HepB-Hib and polio vaccines and
88% of measles. Travel time did not affect vaccination coverage or timeliness. The Kenyan EPI reaches
nearly all children in Kiliﬁ and delays in vaccination are few, suggesting that vaccines will have maximal
impact on child morbidity and mortality.
© 2010 Elsevier Ltd. Open access under CC BY license. . Introduction
The 1980s saw tremendous progress towards universal child-
ood immunization, asmanydeveloping countries received foreign
id and technical support from WHO and UNICEF to build and
ustain national immunization programs. By 1990, coverage with
hree doses of Diphteria–Tetanus–Pertussis vaccine (DTP3) was
aid to have attained 79% globally, though sub-Saharan Africa and
outhern Asia lagged behind other regions, with only 52% and 68%
overage. Limited improvements in coverage have been achieved
ince 1990 [1], but new efforts are underway to establish univer-
al immunization. As part of the polio eradication initiative, many
ountries conduct national and sub-national “catch-up” campaigns
ovaccinate all children, and theGAVIAlliancehas supplied funding
or strengthening routine immunization services since 2000.
Despite these efforts, available data show that inequalities in
mmunization coverage persist across the developing world [2]. At
he country level, stark variations in coverage exist among socio-
conomic groups, and in some cases between sexes [3,4]. Further,
xpansions in coverage do not always produce improvements in
quity [5]. Supplementary immunization activities may serve to
educe these disparities, but they are limited to polio and measles
∗ Corresponding author at: 615N. Wolfe St, E8539, Baltimore, MD, USA.
el.: +1 254 711 574 644.
E-mail address: jmoisi@jhsph.edu (J.C. Moïsi).
264-410X © 2010 Elsevier Ltd. 
oi:10.1016/j.vaccine.2010.06.011
Open access under CC BY license. vaccines and therefore have no beneﬁt for other target diseases.
At the local level, studies have shown increases in coverage with
socio-economic status, higher coverage in non-migrant than in
migrant populations, and delayed administration of vaccines in
the rainy season, in remote areas, and in larger families [6–10].
Though a large body of literature has demonstrated that the likeli-
hood of seeking curative care decreases with increasing distance to
health facilities [11–14], analogous data on immunization are lim-
ited and inconsistent [6,9,15–18]. Children living far from clinics
mayhave the highestmortality risk [10,19,20], supporting the need
to investigatewhether they have equitable access to immunization
services.
With support from GAVI, Kenya plans to introduce pneumococ-
cal conjugate vaccine (PCV) into its routine immunization schedule
in 2010. Vaccine coverage surveys in Kiliﬁ District, Kenya before
and after the introduction of Hib vaccine showed that 88–100% of
children in this area were immunized with three doses of DTP or
DTP-Hepatitis B-Hib (pentavalent) vaccine, but that many received
their vaccines late [9] mirroring ﬁndings from DHS surveys con-
ducted in several developing countries [2]. For diseases with high
incidence in the ﬁrst few months of life such as Haemophilus
inﬂuenzae type b or Streptococcus pneumoniae infections, delays in
immunization may diminish the impact of vaccine even if cover-
age at age 12 months is high. In this context, we sought to identify
predictors of the timing of immunization among infants in Kiliﬁ
District, with a focus on the effect of spatial factors such as distance
to vaccine clinics.
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were enrolled on a second, third and fourth visit, for an overall
enrollment rate of 86.6% (2169/2504). Reasons for non-enrollment
included refusal to participate (23, 6.9%), loss to follow-up after
three or more unsuccessful visits (77, 23%), out-migration to an
unknown location (48, 14.3%), out-migration outside the Epi-DSS
1 Education data were not collected in the immunization coverage survey. We726 J.C. Moïsi et al. / Vac
. Methods
.1. Study site
This study was conducted in Kiliﬁ District, a largely rural
rea situated on the Indian Ocean coast of Kenya. In 2000,
he Kenya Medical Research Institute (KEMRI)/Wellcome Trust
esearch Programme established an Epidemiologic and Demo-
raphic Surveillance System (Epi-DSS) to monitor vital events and
igrations in a 900km2 area around the hospital covering over
20,000 people. Approximately three census rounds have been
ompleted each year since the initial population enumeration. A
urvey of health facilities conducted in September 2006 identiﬁed
7 public, private, or NGO-run immunization clinics serving Kil-
ﬁ District, 16 of which are located within the Epi-DSS area. The
enyan EPI recommends that children receive Bacillus Calmette-
uerin (BCG) and Oral Polio Vaccine (OPV) at birth; three doses of
entavalent vaccine and OPV at 6, 10 and 14 weeks of age; and
easles vaccine at 9 months of age. Immunizations are recorded
n vaccine cards or booklets obtained from the clinics.
.2. Immunization study subjects
All children residing in the Epi-DSS area were eligible for enroll-
ent within 1 month of their ﬁrst birthday. Using the Epi-DSS
opulation register, we selected a 30% simple random sample
f eligible children each month from January to October 2007
nd 20% in November and December 2007. We aimed to enroll
t least 1904 children in order to have 90% power to detect a
ve percentage-point difference in coverage with three doses of
entavalent vaccine between areas close to immunization clinics
assumed to have 90% coverage) and areas far from clinics, at a
igniﬁcance level of 0.05.
.3. Immunization data collection
Fieldworkers visited the homes of all children selected for study
articipation. After obtaining informed consent from the mother
r guardian, they completed a questionnaire listing the date and
ocation each vaccinewas received based on the child’s vaccination
ard or on maternal recall (if the card was unavailable). Given the
arget age at enrollment, very few post-infantile vaccinations were
ecorded. When the ﬁrst home visit was unsuccessful, up to two
ollow-up visits were conducted unless (1) the mother/guardian
efused to participate; (2) the mother/guardian had migrated to
n area outside the Epi-DSS, or to an unknown destination within
he area; (3) no child meeting the study inclusion criteria resided
t the homestead due to an Epi-DSS register error. Mothers who
ad migrated within the Epi-DSS area were sought in their new
esidence.
.4. Mapping and travel time estimation
The Epi-DSS area has been thoroughly mapped using Magel-
an (Magellan Navigation Inc., Santa Clara, CA) and e-Trex (Garmin
td., Olathe, KS) Geographic Positioning Systems (GPS) technology,
ncluding administrative location boundaries, homestead coor-
inates, footpaths, roads, and matatu (local bus) routes with
ssociated transport speeds. All geographic data were imported
ia Datasend, Map Source, or DNRGarmin software into ArcGIS 9.2
ESRI, Redlands, CA) for mapping and analysis.Travel time to vaccine clinics was calculated using an ArcGIS
ost-distance algorithm. The details of this method have been
escribed elsewhere [21]. We constructed an impedance raster (a
rid in which each cell is assigned a friction or inverse speed value)
o deﬁne the speed of travel through each 100-m×100-m area of (2010) 5725–5730
Kiliﬁ District, assuming speeds of 5 km/h on roads and footpaths
and 2.5 km/h off-road for pedestrian travel, and matatu speeds on
matatu routes for vehicular travel. The algorithm uses the raster to
calculate a catchment area for each health facility and travel time
to this facility from all homesteads in its catchment area.
2.5. Vaccine coverage analysis
We calculated the proportion of children receiving a given dose
of vaccine (“vaccine coverage”) among subjects with and without
vaccine cards, by sex, administrative location, ethnic group (indi-
vidual categories for groups with at least 25 survey participants,
“other” category combining groups with <25 participants), mater-
nal education (proportion of women 15–49 years old with any
education in a given sublocation: group 1, <0.5; group 2, 0.5 to <0.6;
group 3, 0.6 to <0.7; and group 4, ≥0.7),1 migrant status (migrant:
migration from outside the Epi-DSS area between 2000 and 2006),
and month of birth, and compared coverage across strata using
chi-square tests. For children with vaccine cards, we obtained cov-
erage at speciﬁc time points and median and inter-quartile ranges
for age at vaccination. We constructed inverse Kaplan–Meier sur-
vival curves for immunization with one, two and three doses of
pentavalent vaccine and compared time-to-immunization across
strata using log-rank tests. We built multivariable Cox propor-
tional hazards models to investigate the effects of travel time to
vaccine clinics, sex, ethnic group, maternal education, migration
and season (rainy: April–June and October–November) on time-
to-immunization with any dose of pentavalent vaccine, with each
child contributing survival time from 14 days of age for dose one
and from the date of the previous dose for doses two and three.
Children with missing dates of vaccination were excluded from
individual analyses as appropriate. We used a spatial bootstrap
method with 100 repetitions to account for the intra-subject cor-
relation induced by repeat observations from individual children
and the inter-subject correlation engendered by spatial clustering
of immunization events. In each repetition, we randomly selected
40 sublocations (with replacement) and estimated the propor-
tional hazards model on all data from the selected sublocations.
Variables without statistically signiﬁcant effects (at the 0.05 level)
based on Wald tests were dropped from the multivariable models.
Complementary log–log graphs and Wald tests for time-varying
covariates were used to assess the validity of the proportional-
hazards assumption. All analyses were conducted in Stata 9.2
(StataCorp, College Station, TX).
3. Results
3.1. Enrollment
We randomly selected 2504 eligible subjects from the popu-
lation register. Of these, 1804 were enrolled on the ﬁrst home
visit and an additional 271 (of 509), 82 (of 180) and 12 (of 28)therefore used data obtained from all residents of the Epi-DSS during the sixth cen-
sus round (April–August 2004) to calculate the proportion ofwomenof childbearing
age with any schooling in each administrative sublocation and used it to generate
a sublocation-level categorical variable (proportion of mothers with any education
<0.5; 0.5 to <0.6; 0.6 to <0.7; and ≥0.7), which was then applied to individuals based
on their residence.
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rea (136, 40.6%), database error (e.g. mapping error, age error: 47,
4%), andﬁeldwork error (4, 1.2%). Enrollment attained95.4%when
ut-migrants and database errors were excluded. Monthly enroll-
ent ranged from79% to 93.7%,with 155–303 subjects visited each
onth (83 in December 2007).
Survey respondents for the 2169 enrolled children included
859 mothers, 131 fathers and 179 other relatives. Vaccine cards
ere available for 1870 subjects (86.2%). Enrolled children were
orn between March 29th, 2005 and December 31st, 2006. Median
ge at enrollment was 12.5 months (IQR: 12.0–13.1) and did not
ary over the course of the study (11.8–13.3 months). Children less
han 11 months of age at enrollment were excluded from further
nalyses (N=41).
Vaccine card retention varied by location, ranging from 76.6% to
6.4% (p=0.01). Children without cards (N=296) were more likely
o be girls than those with cards (N=1832) (55% vs. 47%, p=0.01),
ut were not signiﬁcantly different with regard to ethnic group or
aternal education.
.2. Coverage in children with and without vaccine cards
Coverage in children with cards was high, attaining 98.9% for
CG, 95.7% for three doses of pentavalent vaccine, 95.6% for three
oses of OPV and 89.7% for measles vaccine. Three-quarters of vac-
inated children received their vaccines within 1 month (30 days)
f the recommended age for all but the third doses of pentavalent
nd OPV, for which the 75th percentile was reached 44 and 38 days
ate, respectively (Table 1).
For all vaccines except the birth dose of OPV, coveragewas three
o seven percentage points higher for children with vaccine cards
han for children without vaccine cards, and the differences in cov-
rage were statistically signiﬁcant (p<0.001) (Table 2). Only OPV0
overage was higher by maternal recall than by card (86.2% vs.
1.1%, p<0.001).
.3. Coverage by sex, location, ethnic group, maternal education,
igrant status and month of birth
In children with vaccine cards, coverage varied by geographic
ocation for OPV0 (27.2% in Ziani to 73% in Kiliﬁ Township,
< 0.001), Penta3 (88.9% in Jaribuni to 100% in Banda ra Salama,
= 0.02), OPV3 (88.1% in Roka to 98.8% in Banda ra Salama, p=0.01)
nd measles vaccine (76.3% in Kauma to 95% in Kiliﬁ Township,
< 0.001); coverage was similar across locations for all other vac-
ines (Fig. 1). Coverage varied by month of birth for BCG, OPV0 and
PV1, ranging from 96.6% to 100%, 35.5% to 58.8%, and 96.4% to
00% respectively, with no seasonal patterns. Coverage by sex, eth-
ic group, maternal education, and migrant status for each of the
accines is shown in Table 3. With the exception of OPV0, there
ere limited variations in coverage across categories for each of
hese attributes.
.4. Time-to-immunization
Pedestrian and vehicular travel times to vaccine clinics ranged
rom0 to170min (median: 47min, inter-quartile range27–73) and
to 132min (median: 27min, inter-quartile range 14–40), respec-
ively. Log-rank tests showed differences in time-to-immunization
ith two or three doses of pentavalent vaccine across pedestrian
ravel time strata (p=0.02), but no clear trends with either pedes-
rian or vehicular travel time (Fig. 2).Travel timewasnot associatedwith time-to-immunizationwith
entavalent vaccine in bivariate or multivariable proportional haz-
rds models (HR=1.00 for pedestrian and HR=1.01 for vehicular
ravel time). In bivariate models, children in the most educated
reas had higher immunization rates than those in less edu- Ta
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Fig. 1. Immunization coverage for OPV0, Penta3, and
Table 2
Percentage of childrenwith andwithout immunization cardswhohad received each
of the EPI vaccinesa.
Vaccine Vaccine coverage at
12m among those with
a card (%)
Vaccine coverage at
12m among those
without a card (%)
BCG 99.0 94.3
Pentavalent 1 99.7 95.3
Pentavalent 2 98.8 93.6
Pentavalent 3 95.7 91.2
OPV0 51.1 86.2
OPV1 99.7 94.9
OPV2 98.9 94.6
OPV3 95.6 92.6
Measles 89.7 82.8
a If vaccination status was unknown, we assumed vaccine was not received.
Table 3
Percentage of children with vaccination cards who had received each of the EPI vaccines,
BCG Penta1 Penta2 Penta3
Sex
Female 99.2 99.8 99.0 95.3
Male 98.8 99.6 98.7 95.6
p-value* 0.38 0.51 0.57 0.81
Ethnicity
Giriama 99.0 99.5 98.9 95.9
Chonyi 99.2 100.0 98.8 96.3
Kauma 98.5 99.0 98.5 94.3
Duruma 100.0 100.0 100.0 96.4
Jibana 98.3 100.0 100.0 93.1
Other 98.3 100.0 98.3 94.1
p-value 0.88 0.32 0.95 0.75
Education
<0.5 99.1 99.6 98.7 96.1
0.5- <0.6 99.4 99.7 99.0 96.7
0.6- <0.7 98.6 99.5 98.1 92.3
≥0.7 98.2 100.0 99.4 98.2
p-value 0.54 0.81 0.44 <0.01
Migration
Non-mig 98.9 99.7 98.7 95.8
Migrant 99.4 99.7 99.0 94.8
p-value 0.45 0.98 0.67 0.44
Statistically signiﬁcant ﬁndings are indicated in bold.
* p-values based on a chi-square tests for proportion.measles vaccines at time of survey, by location.
cated areas (HR[group 4 vs. groups 1–3] =1.22, 95% CI 1.17–1.28)
and migrant children had slightly higher rates than non-migrants
(HR=1.04, 95% CI 1.01–1.07), but these effects disappeared after
adjusting for travel time. The only signiﬁcant predictor of immu-
nization rates in the ﬁnal model was season, with lower rates
observed in the rains than in the dry season (HR=0.86, 95% CI:
0.81–0.92).
4. DiscussionThis large-scale survey of young children in Kiliﬁ District, Kenya
showed very high immunization coverage for all recommended
vaccines, with 98.9%, 95.7%, 95.6% and 89.7% of subjects with vac-
cine cards receiving BCG, three doses of pentavalent, three doses of
OPV, and measles vaccines by the age of 1 year, respectively. Only
by sex, ethnic group, maternal education and migrant status.
OPV0 OPV1 OPV2 OPV3 Measles
50.9 99.8 99.0 95.7 88.8
51.3 99.6 98.7 95.5 90.4
0.88 0.51 0.57 0.83 0.25
52.6 99.7 98.9 95.6 91.3
42.7 99.8 98.8 95.7 88.1
50.5 99.5 98.5 94.9 83.5
60.7 100.0 100.0 96.4 92.9
65.5 100.0 100.0 100.0 93.1
77.1 99.2 98.3 94.9 94.1
<0.01 0.88 0.95 0.88 <0.01
42.2 100.0 98.7 95.7 85.7
47.3 99.6 99.2 96.7 90.4
53.5 99.5 97.6 92.3 87.7
80.4 100.0 99.4 97.6 95.8
<0.01 0.63 0.08 <0.01 <0.01
49.5 99.7 98.8 95.7 89.3
58.3 99.7 98.7 94.8 90.9
<0.01 0.98 0.88 0.50 0.39
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4% of enrolled subjects did not have vaccine cards available for
xamination. In this group, reported coverage was three to seven
ercentage points lower for all doses of vaccine (except OPV0),
ut remained >90% for BCG, DTP-HepB-Hib3, OPV3 and >80% for
easles. The wide discrepancy between maternal reporting and
ard data for OPV0 coverage is speciﬁc to this vaccine, and may
eﬂect poor recall for the period immediately after delivery. The
eliability of mothers’ histories was previously evaluated in this
etting among 18 children enrolled in a small immunization cov-
rage survey, showing that 100% of mothers correctly recalled the
rst dose of DTP, 94% the second dose and 88% the third dose [9].
vidence from other regions is conﬂicting, with some studies sug-
esting thatmaternal recall has lowaccuracy [22–27].Most of these
tudies were conducted in industrialized countries and data from
iliﬁ, Egypt [23] or Sudan [28] may be more relevant for our anal-
sis. Regardless of the reliability of maternal recall, we calculated
hat evenwith0% coverage in childrenwithout cards, overall cover-
ge for BCG, Pentavalent-3 (orOPV3) andmeasleswould attain85%,
2% and 77%, respectively; these values would increase to 92%, 89%
nd 84% with 50% coverage in children without cards. In addition
o recall bias, our results may be subject to survivor bias because
e only sampled children who were alive and 6–11 months of age
t the time of the last Epi-DSS census. The 2006 birth cohort had
n infant mortality ratio of 37 per 1000 live births (unpublished
ata, Kiliﬁ Epi-DSS): even if none of these children were vacci-
ated, BCG, pentavalent-3, and measles coverage would only be
educed to 95%, 92% and 86%, respectively. Together, these results
trengthen the evidence from earlier, smaller studies conducted
rom 2002 to 2004 [9], and attest to the success of the Kenyan EPI
n reaching a large majority of children in Kiliﬁ. They also concur
ith data from the 2008 Kenya Demographic and Health Survey
unpublished data, Kenya 2008 DHS) and WHO/UNICEF joint esti-
ates [29] that showed approximately 95% coveragewith BCG, 85%
ith Penta3, and 85–90% with measles vaccine on a national level.
We sought to investigate spatial variations in immunization
overage, and found that these were relatively limited in the
tudy area. For Penta3, OPV3 and measles, we observed disparities
cross administrative locations, with 89–100% coverage for Penta3,
8–99% for OPV3 and 80–92% for measles. Time-to-immunization
aried by location aswell: children in Kiliﬁ Township received each
ose of pentavalent vaccine earlier than their peers in rural areas.
owever, the hypothesis that improved physical access to vaccine
linics increases the timeliness of immunization was not substan-
iated by our data. This ﬁnding may stem from a number of factors.
irst, travel time to vaccine clinics varied little within the Epi-DSS.ine, by pedestrian and vehicular travel time to vaccine clinics.
Maximum pedestrian and vehicular travel times to vaccine clin-
ics were less than 3h and less than 2.5h, respectively, with 75% of
children residing less than 72min on foot and less than 42min by
vehicle from a clinic. In this context, traveling to clinics may not
impose a signiﬁcant burden on families or hamper timely immu-
nization. Second,wewere unable to account for several factors that
may confound the association between time-to-immunization and
physical access to care. We employed sublocation-level maternal
education as a proxy for socio-economic status and were there-
fore unable to reﬂect inequalities in socio-economic status within
sublocations, whichmay be associated bothwith distance to clinics
and timing of immunization. Further, we were unable to account
for family size or birth intervals in ourmodel. Parity and birth inter-
vals may affect time-to-immunization and are likely to vary with
distance to clinics; they may therefore be important confounders
as well [9,30].
We have previously shown that travel time is a barrier to hospi-
tal admission in theKiliﬁ Epi-DSS (JMoïsi, submitted). Assuming no
residual confounding, the absence of a relationship between time-
liness of vaccination and distance to clinics in this analysis suggests
that programmatic differences between immunization and hospi-
tal service delivery play an important role in service utilization.
Programmatic factors contributing to high immunization coverage
may include the decentralized provision of immunization services,
the perceived high quality of these services, or the focus on proac-
tive outreach efforts via Supplementary Immunization Activities
(SIAs) andmobile clinic teamactivities.Measles andpolio SIAswere
conducted in Kiliﬁ District in the second half of 2006, but should
have no effect on pentavalent vaccine coverage since the vaccine
was not delivered through this mechanism. Outreach via mobile
teams was donor-funded, localized, and sporadic during the study
period yet may have contributed to high coverage as well.
While no variations in time-to-immunization were seen with
travel time to vaccine clinics, other key predictors of immunization
rates were identiﬁed in this study. At a given age, children were
14% less likely to be immunized with pentavalent vaccine during
the rains than during the dry season: the rainy season coincides
with the harvest and impedes travel, even for short distances. How-
ever, coverage with three doses of pentavalent and OPV vaccines
at age 12 months did not vary by month of birth, suggesting that
delays in receiving individual doses do not correlate with a long-
term decrease in the likelihood of vaccination. Secondly, residing
in an area with high levels of maternal education or belonging to
a migrant family was associated with an increase in immunization
rates in bivariate analyses. These effects disappeared in multivari-
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ble analyses, reﬂecting possible confounding by travel time to
accine clinics. Overall, however, the effect of maternal education
roduced higher coverage with three doses of pentavalent vac-
ine at age 12 months in the most educated areas compared to the
ess educated ones. This result is consistent with 2008 Kenya DHS
ata showing substantially higher coverage for all vaccines in chil-
ren with educated mothers compared to those with uneducated
others (unpublished data, Kenya 2008 DHS), and buttresses the
otion of a strong relationship between maternal education and
hild health.
Geographic access to care in the Kilﬁ Epi-DSS is comparable to
ost other regions of Kenya [31] and immunization coverage is
imilarly high based on data from the most recent Demographic
nd Health Survey and WHO/UNICEF joint coverage estimates. It
s therefore likely that the vast majority of Kenyan children enjoy
s equitable and timely access to immunization as do residents of
ur study area. In this context, the introduction of a new, effective
accine against pneumococcal disease is likely to reach all children
t anearly ageand lead to substantial improvements in childhealth.
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